Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-16

Clinical Trial Update: Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

View source ↗

Summary

This document reports real-world observational findings on the effectiveness of dupilumab in patients with prurigo nodularis. The study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Prurigo Nodularis | Status: ACTIVE_NOT_RECRUITING